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Summary: Comparing large covariance matrices has important applications in modern genomics, where scientists
are often interested in understanding whether relationships (e.g., dependencies or co-regulations) among a large
number of genes vary between different biological states. We propose a computationally fast procedure for testing
the equality of two large covariance matrices when the dimensions of the covariance matrices are much larger than
the sample sizes. A distinguishing feature of the new procedure is that it imposes no structural assumptions on the
unknown covariance matrices. Hence the test is robust with respect to various complex dependence structures that
frequently arise in genomics. We prove that the proposed procedure is asymptotically valid under weak moment
conditions. As an interesting application, we derive a new gene clustering algorithm which shares the same nice
property of avoiding restrictive structural assumptions for high-dimensional genomics data. Using an asthma gene
expression dataset, we illustrate how the new test helps compare the covariance matrices of the genes across different
gene sets/pathways between the disease group and the control group, and how the gene clustering algorithm provides
new insights on the way gene clustering patterns differ between the two groups. The proposed methods have been
implemented in an R-package HDtest and is available on CRAN.
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Testing Large Covariance Matrices 1
1. Introduction
The problem of comparing two large population covariance matrices has important appli-
cations in modern genomics, where growing attentions have been devoted to understanding
how the relationship (e.g. dependencies or co-regulations) among genes vary between different
biological states. Our interest in this problem is motivated by a microarray study on human
asthma (Voraphani et al., 2014). This study consists of 88 asthma patients and 20 controls.
It is known that genes tend to work collectively in groups to achieve certain biological tasks.
Our analysis focuses on such groups of genes (gene sets) defined with the gene ontology
(GO) framework, which are referred to as GO terms. Identifying GO terms with altered
dependence structures between disease and control groups provides critical information on
differential gene pathways associated with asthma. Many of the GO terms contain a large
number of (in the asthma data, as many as 8,070) genes. The large dimension of microarray
data and the complex dependence structure among genes make the problem of comparing
two population matrices extremely challenging.
In conventional multivariate analysis where the dimension p is fixed, testing the equality
of two unknown covariance matrices Σ1 and Σ2 based on the samples with sample sizes n
and m has been extensively studied, see for example Anderson (2003) and the references
therein. In the high-dimensional setting where p > max(n,m), recently several authors have
developed new tests other than the traditional likelihood ratio test. Considering multivariate
normal data, Schott (2007) and Srivastava and Yanagihara (2010) constructed tests using
different distances based on traces of the covariance matrices; Li and Chen (2012) proposed
a U -statistic based test for a more general multivariate model. These tests are effective for
dense alternatives, but often suffer from low power when Σ1 − Σ2 is sparse. We are more
interested in this latter situation, as in genomics the difference in the dependence structures
between populations typically involves only a small number of genes.
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For sparse alternatives, Cai et al. (2013) investigated an L∞-type test. They proved that
the distribution of the test statistic converges to a type I extreme value distribution under the
null hypothesis and the test enjoys certain optimality property. Motivated by this work, we
propose in this paper a perturbed variation of the L∞-type test statistic. We verify that the
conditional distribution of the perturbed L∞-statistic provides a high-quality approximation
to the distribution of the original L∞-type test, which has important implications in achieving
accurate performance in finite sample size. In contrast, the convergence rate to the extreme-
value distribution of type I is of order O{log(log n)/ log n} (Liu et al., 2008).
The asymptotic validity of our proposed new procedure does not require any structural
assumptions on the unknown covariances. It is valid under weak moment conditions. On the
other hand, the aforementioned work all require certain parametric distributional assump-
tions or structural assumptions on the population covariances in order to derive an asymp-
totically pivotal distribution. Assumptions of this kind are not only difficult to be verified but
also often violated in real data. It is known that expression levels of the genes regulated by the
same pathway (Wolen and Miles, 2012) or associated with the same functionality (Katsani et
al., 2014) are often highly correlated. Also, in the microarray and sequencing experiments,
most genes are expressed at very low levels while few are expressed at high levels. This
implies that the distribution of gene expressions is most likely heavy-tailed regardless of the
normalization and transformations (Wang et al., 2015).
For testing H0 : Σ1 = Σ2 in high dimensions, the new procedure is computationally
fast and adaptive to the unknown dependence structures. Section 2 introduces the new
testing procedure and investigates its theoretical properties. In Section 3, we compare its
finite sample performance with several competitive procedures. A gene clustering algorithm
is derived in Section 4, which aims to group hundreds or thousands of genes based on the
expression patterns (Sharan et al., 2002) without imposing restrictive structural assumptions.
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We apply the proposed procedures to the human asthma dataset in Section 5. Section 6
discusses our results and other related work. Proofs of the theoretical results and additional
numerical results are provided in the Supplementary Material. The proposed methods have
been implemented in the R package HDtest and is currently available on CRAN (http:
//cran.r-project.org).
2. The new testing procedure
2.1 The L∞-statistic
Let X = (X1, . . . , Xp)
T and Y = (Y1, . . . , Yp)
T be two p-dimensional random vectors with
means µ1 = (µ11, . . . , µ1p)
T and µ2 = (µ21, . . . , µ2p)
T, and covariance matrices Σ1= (σ1,k`)16k,`6p
and Σ2= (σ2,k`)16k,`6p, respectively. We are interested in testing
H0 : Σ1 = Σ2 versus H1 : Σ1 6= Σ2 (2.1)
based on independent random samples Xn = {X1, . . . ,Xn} and Ym = {Y1, . . . ,Ym} drawn
from the distributions of X and Y, respectively. For each i and j, we write Xi = (Xi1, . . . , Xip)
T
and Yj = (Yj1, . . . , Yjp)
T. Let Σ̂1 = (σˆ1,k`)16k,`6p = n
−1∑n
i=1(Xi − X¯)(Xi − X¯)T and
Σ̂2 = (σˆ2,k`)16k,`6p = m
−1∑m
j=1(Yj − Y¯)(Yj − Y¯)T be the sample analogues of Σ1 and
Σ2, where X¯ = (X¯1, . . . , X¯p)
T = n−1
∑n
i=1 Xi and Y¯ = (Y¯1, . . . , Y¯p)
T = m−1
∑m
j=1 Yj.
For each (k, `), a straightforward extension of the two-sample t-statistic for the marginal
hypothesis H0,k` : σ1,k` = σ2,k` versus H1,k` : σ1,k` 6= σ2,k` is given by
tˆk` =
σˆ1,k` − σˆ2,k`
(n−1sˆ1,k` +m−1sˆ2,k`)1/2
, (2.2)
where sˆ1,k` = n
−1∑n
i=1{(Xik−X¯k)(Xi`−X¯`)− σˆ1,k`}2 and sˆ2,k` = m−1
∑m
j=1{(Yjk− Y¯k)(Yj`−
Y¯`)−σˆ2,k`}2 are estimators of s1,k` = Var{(Xk−µ1k)(X`−µ1`)} and s2,k` = Var{(Yk−µ2k)(Y`−
µ2`)}, respectively.
Since the null hypothesis in (2.1) is equivalent to H0 : max16k6`6p |σ1,k` − σ2,k`| = 0, a
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natural test statistic that is powerful against sparse alternatives in (2.1) is the L∞-statistic
T̂max = max
16k6`6p
|tˆk`|. (2.3)
2.2 A new testing procedure
One way to base a testing procedure on the L∞-statistic is to reject the null hypothesis (2.1)
when T̂ 2max − 4 log p+ log(log p) > qα, where qα = − log(8pi)− 2 log log(1− α)−1 corresponds
to the (1−α)-quantile of the type I extreme value distribution. Cai et al. (2013) proved that
this leads to a test that maintains level α asymptotically and enjoys certain optimality.
In this section, we propose a new test that rejects (2.1) when T̂max > cα, where cα is
obtained using a fast-computing data perturbation procedure. The new procedure resolves
two issues at once. First, it achieves better finite sample performance by avoiding the slow
convergence of T̂ 2max−4 log p+log(log p) to the type I extreme value distribution. Second and
more importantly, our procedure relaxes the conditions on the covariance matrices required
in Cai et al. (2013) (particularly, their Conditions (C1) and (C3)). Note that their Condition
(C1) essentially requires that the number of variables that have non-degenerate correlations
with others should grow no faster than the rate of p. Although this condition is reasonable
in some applications, it is hard to be justified for data from the microarray or transcriptome
experiments, where the genes can be divided into gene sets with varying sizes according to
functionalities, and usually genes from the same set have relatively high (sometimes very
high) intergene correlations compared to those from different sets. This corresponds to an
approximate block structure. Many sets can contain several thousand genes, a polynomial
order of p. This kind of block structure with growing block size may violate Condition (C1)
in Cai et al. (2013). The crux of the derivation of the asymptotic type I extreme value
distribution in (Cai et al., 2013) is that the tˆk`’s are weakly dependent under H0 under
certain regularity conditions. In contrast, the new procedure we present below automatically
takes into account correlations among the tˆk`’s.
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Specifically, we propose the following procedure to compute cα with the dependence among
tˆk`’s incorporated.
(I). Independent of Xn and Ym, we generate a sequence of independent N(0, 1) random
variables g1, . . . , gN , where N = n+m is the total sample size.
(II). Using the gi’s as multipliers, we calculate the perturbed version of the test statistic
T̂ †max = max
16k6`6p
|tˆ †k`|, (2.4)
where tˆ †k` = (n
−1sˆ1,k` +m−1sˆ2,k`)−1/2(σˆ
†
1,k`− σˆ†2,k`) with σˆ†1,k` = n−1
∑n
i=1 gi{(Xik− X¯k)(Xi`−
X¯`)− σˆ1,k`} and σˆ†2,k` = m−1
∑m
j=1 gn+j{(Yjk − Y¯k)(Yj` − Y¯`)− σˆ2,k`}.
(III). The critical value cα is defined as the upper α-quantile of T̂
†
max conditional on
{Xn,Ym}; that is, cα = inf
{
t ∈ R : Pg(T̂ †max > t) 6 α
}
, where Pg denotes the probability
measure induced by the Gaussian random variables {gi}Ni=1 with Xn and Ym being fixed.
This algorithm combines the ideas of multiplier bootstrap and parametric bootstrap. The
principle of parametric bootstrap allows tˆ †k`’s constructed in step (II) to retain the covariance
structure of tˆk`’s. The validity of multiplier bootstrap is guaranteed by the multiplier central
limit theorem, see van der Vaart and Wellner (1996) for traditional fixed- and low-dimensional
settings and Chernozhukov et al. (2013) for more recent development in high dimensions.
For implementation, it is natural to compute the critical value cα via Monte Carlo sim-
ulation by cB,α = inf{t ∈ R : 1 − F̂B(t) 6 α}, where F̂B(t) = B−1
∑B
b=1 I(T̂
†
b 6 t) and
T̂ †1 , . . . , T̂
†
B are B independent realizations of T̂
†
max in (2.4) by repeating steps (I) and (II).
For any prespecified α ∈ (0, 1), the null hypothesis (2.1) is rejected whenever T̂max > cB,α.
The main computational cost of our procedure for computing the critical value cB,α only
involves generating NB independent and identically distributed N(0, 1) variables. It took
only 0.0115 seconds to generate one million such realizations based on a computer equipped
with Intel(R) Core(MT) i7-4770 CPU @ 3.40GHz. Hence even taking B to be in the order
of thousands, our procedure can be easily accomplished efficiently when p is large.
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2.3 Theoretical properties
The difference between cα and its Monte Carlo counterpart cB,α is usually negligible for a
large value of B. In this section, we study the asymptotic properties of the proposed test
Ψα = I{T̂max > cα} under both the null hypothesis (2.1) and a sequence of local alternatives.
For the asymptotic properties, we only require the following relaxed regularity conditions.
Let K > 0 be a finite constant independent of n,m and p.
(C1). {E(|Xk|2r)}1/r 6 Kσ1,kk, {E(|Yk|2r)}1/r 6 Kσ2,kk uniformly in k = 1, . . . , p, for some r > 4.
(C2). max16k6p E{exp(κX2k/σ1,kk)} 6 K and max16`6p E{exp(κY 2` /σ2,``)} 6 K for some κ > 0.
(C3). min16k6`6p s1,k`/(σ1,kkσ1,``) > c and min16k6`6p s2,k`/(σ2,kkσ2,``) > c for some c > 0.
(C4). n and m are comparable, i.e. n/m is uniformly bounded away from zero and infinity.
Assumptions (C1) and (C2) specify the polynomial-type and exponential-type tails condi-
tions on the underlying distributions of X and Y, respectively. Assumption (C3) ensures that
the random variables {(Xk−µ1k)(X`−µ1`)}16k,`6p and {(Yk−µ2k)(Y`−µ2`)}16k,`6p are non-
degenerate. The moment assumptions, (C1)–(C3), for the proposed procedure are similar to
Conditions (C2) and (C2∗) in Cai et al. (2013). Assumption (C4) is a standard condition in
two-sample hypothesis testing problems. As discussed before, no structural assumptions on
the unknown covariances are imposed for the proposed procedure. Theorem 1 below shows
that, under these mild moment and regularity conditions, the proposed test Ψα with cα
defined in Section 2.2 has an asymptotically α.
Theorem 1: Suppose that Assumptions (C3) and (C4) hold. If either Assumption (C1)
holds with p = O(nr/2−1−δ) for some constant δ > 0 or Assumption (C2) holds with log p =
o(n1/7), then as n,m→∞, PH0(Ψα = 1)→ α uniformly over α ∈ (0, 1).
Remark 1: The asymptotic validity of the proposed test is obtained without imposing
structural assumptions on Σ1 and Σ2, nor do we specify any a priori parametric shape
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constraints of the data distributions, such as Condition A3 in Li and Chen (2012) or
Conditions (C1) and (C3) in Cai et al. (2013).
Next, we investigate the asymptotic power of Ψα. It is known that the L∞-type test
statistics are preferred to the L2-type statistics, including those proposed by Schott (2007)
and Li and Chen (2012), when sparse alternatives are under consideration. As discussed in
Section 1, the scenario in which the difference between Σ1 and Σ2 occurs only at a small
number of locations is of great interest in a variety of scientific studies. Therefore, we focus
on the local sparse alternatives characterized by the following class of matrices
M(γ) =
{
(Σ1,Σ2) : Σ1 and Σ2 are positive semi-definite matrices satisfying
Assumption (C3) and max
16k6`6p
|σ1,k` − σ2,k`|
(n−1s1,k` +m−1s2,k`)1/2
> (log p)1/2γ
}
.
Theorem 2 below shows that, with probability tending to 1, the proposed test Ψα is able to
distinguish H0 from the alternative H1 whenever (Σ1,Σ2) ∈M(γ) for some γ > 2.
Theorem 2: Suppose that Assumptions (C3) and (C4) hold. If either Assumption 1
holds with p = O(nr/2−1−δ) for some constant δ > 0 or Assumption 2 holds with log p =
o(n1/2), then as n,m→∞, inf(Σ1,Σ2)∈M(γ) PH1(Ψα = 1)→ 1 for any γ > 2.
Theorem 2 of Cai et al. (2013) requires γ = 4 to guarantee the consistency of their proce-
dure. Moreover, they showed that the rate (log p)1/2n−1/2 for the lower bound of the maximum
magnitude of the entries of Σ1 −Σ2 is minimax optimal, that is, for any α, β > 0 satisfying
α + β < 1, there exists a constant γ0 > 0 such that inf(Σ1,Σ2)∈M(γ0) supTα∈Tα PH1(Tα = 1) 6
1− β for all sufficiently large n and p, where Tα is the set of α-level tests over the collection
of distributions satisfying Assumptions (C1) and (C2). Hence, our proposed test also enjoys
the optimal rate and is powerful against sparse alternatives.
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3. Simulation studies
In this section, we compare the finite-sample performance of the proposed new test with
that of several alternative testing procedures, including Schott (2007) (Sc hereafter), Li
and Chen (2012) (LC hereafter) and Cai et al. (2013) (CLX hereafter). We generated two
independent random samples {Xi}ni=1 and {Yj}mj=1 such that Xi = Σ1/21,∗Z(1)i and Yj =
Σ
1/2
2,∗Z
(2)
j with Z
(1)
i = (Z
(1)
i1 , . . . , Z
(1)
ip )
T and Z
(2)
j = (Z
(2)
j1 , . . . , Z
(2)
jp )
T, where Z
(1)
i1 , . . . , Z
(1)
ip and
Z
(2)
j1 , . . . , Z
(2)
jp are two sets of independent and identically distributed (i.i.d.) random variables
with variances σ2Z,1 and σ
2
Z,2, such that Σ1 = σ
2
Z,1Σ1,∗ and Σ2 = σ
2
Z,2Σ2,∗. We assess the
performance of the aforementioned tests under the null hypothesis (2.1). Let Σ1,∗ = Σ2,∗ =
Σ∗ and consider the following four different covariance structures for Σ∗.
• M1 (Block diagonals): Set Σ∗ = D1/2AD1/2, where D is a diagonal matrix whose diagonals
are i.i.d. random variables drawn from Unif(0.5, 2.5). Let A = (ak`)16k,`6p, where akk = 1,
ak` = 0.55 for 10(q − 1) + 1 6 k 6= ` 6 10q for q = 1, . . . , bp/10c, and ak` = 0 otherwise.
• M2 (Slow exponential decay): Set Σ∗ = (σk`,∗)16k,`6p, where σk`,∗ = 0.99|k−`|1/3 .
• M3 (Long range dependence): Let Σ∗ = (σk`,∗)16k,`6p with i.i.d. σkk,∗ ∼ Unif(1, 2), and
σk`,∗ = ρα(|k − `|), where ρα(d) = {(d+ 1)2H + (d− 1)2H − 2d2H}/2 with H = 0.85.
• M4 (Non-sparsity): Define matrices F = (fk`)16k,`6p with fkk = 1, fk,k+1 = f`+1,` = 0.5,
U ∼ U(Vp,k0), the uniform distribution on the Stiefel manifold (i.e. U ∈ Rp×k0 and UTU =
Ik0 , the k0-dimensional identity matrix), and diagonal matrix D with diagonal entries being
i.i.d. Unif(1, 6) random variables. We took k0 = 10 and Σ∗ = D1/2(F + UUT)D1/2.
In practice, non-Gaussian measurements are particularly common for high throughput data,
such as data with heavy tails in microarray experiments and data of count type with zero-
inflation in image processing. To mimic these practical scenarios, we considered the following
three models of innovations Z
(1)
ik and Z
(2)
jk to generate data.
• (D1) Let Z(1)ik and Z(2)jk be Gamma random variables: Z(1)ik , Z(2)jk ∼ Gamma(4, 10).
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• (D2) Let Z(1)ik and Z(2)jk be zero-inflated Poisson random variables: Z(1)ik , Z(2)jk ∼ Pois(1000)
with probability 0.15 and equals to zero with probability 0.85.
• (D3) Let Z(1)ik and Z(2)jk be Student’s t random variables: Z(1)ik ∼ t5 and Z(2)jk ∼ t5(µ) with
non-central parameter µ drawn from Unif(−2, 2).
For the numerical experiments, (n1, n2) was taken to be (45, 45) and (60, 80), and the
dimension p took value in {80, 280, 500, 1000}. To compute the critical value for the proposed
test ΨB,α, B was taken to be 1500.
[Table 1 about here.]
[Table 2 about here.]
Tables 1 and 2 display the empirical sizes of ΨB,α, the LC test, Sc test and CLX test.
For both the Gamma and zero-inflated Poisson data (models D1 and D2), the Sc test fails
to maintain the nominal size while the other three tests maintain the significance level
reasonably well. For the t-distributed data (model D3), both the Sc and LC tests had
distorted empirical sizes. In contrast, the proposed test ΨB,α has empirical size closer to
the nominal level for the t-distributed data while the CLX test is more conservative. This
confirms the early discussions that the limiting distribution based approach for L∞-type
test procedure can sometimes be conservative. Compared to the existing methods, ΨB,α
has a much wider applicability as it requires no structural assumptions on the unknown
covariances and circumvents the issue of slow convergence of L∞-type statistic to its limiting
distribution. Overall, ΨB,α maintains the nominal size in finite sample reasonably well and
is robust against unknown covariance structures as well as data generation mechanisms.
To evaluate the power performance against relatively sparse alternatives, we define a
perturbation matrix Q with b0.05pc random non-zero entries. Half of the non-zero entries
are randomly allocated in the upper triangle part of Q and the others are in its lower
triangle part by symmetry. The magnitudes of non-zero entries are randomly generated from
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Unif(τ/2, 3τ/2) with τ = 8 max{max16k6p σkk,∗, (log p)1/2}, where σkk,∗’s are the diagonal
entries of Σ∗ specified before. We take Σ1,∗ = Σ∗ + λ0Ip and Σ2,∗ = Σ∗ + Q + λ0Ip, where
λ0 = |min{λmin(Σ∗+Q), λmin(Σ∗)}|+0.05 with λmin(A) denoting the smallest eigenvalue of
matrix A. For the Gamma and zero-inflated Poisson data (panels for D1 and D2 in Figure 1),
only the proposed test ΨB,α, the LC and CLX tests are considered since the Sc test is no
longer applicable due to inflated sizes; and similarly, for the t-distributed data (panels for
D3 in Figure 1), only ΨB,α and the CLX test are considered.
[Figure 1 about here.]
Figure 1 displays empirical power comparisons. We see that the proposed test ΨB,α and
the CLX test are substantially more powerful than the LC test against sparse alternatives
for the Gamma and zero-inflated Poisson data (data models D1 and D2) under different
covariance structures. As the number of non-zero entries of Σ1 − Σ2 grows in p, both the
proposed test ΨB,α and the CLX test gain powers while the LC test do not gain much due to
the sparsity of Σ1 −Σ2. For the Gamma and zero-inflated Poisson data, the proposed test
is slightly more powerful than the CLX test when the sample size is small and the two tests
are closely comparable as the sample size increasing. For t-distributed data (data model D3),
ΨB,α is more powerful than the CLX test and gains more powers along increasing sample
sizes and dimensions. In summary, ΨB,α outperforms the other three for sparse alternatives
of interest. More simulation results are reported in the supplementary material.
4. Application of the proposed procedure in gene clustering
The primary goal of gene clustering is to group genes with similar expression patterns
together, which usually provides insights on their biological functions or regulatory pathways.
In genomic studies, gene clustering has been employed for detecting co-expression gene sets
(D’haeseleer, 2005; Sharan et al., 2002), identifying functionally related genes (Yi et al.,
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2007), and discovering large groups of genes suggestive of co-regulation by common factors,
among other applications.
Consider a random sample Xn = {X1, . . . ,Xn} of n independent observations from X =
(X1, . . . , Xp)
T with covariance Σ1 = (σ1,k`)16k,`6p and correlation R1 = (ρ1,k`)16k,`6p, where
Xi records the expression levels of p genes from subject i. To cluster the genes based on their
expression levels, some dissimilarity or proximity measure for the p genes, or equivalently,
the p variables, is calculated based on Xn, to which clustering algorithms are applied. Gene
clustering can therefore be achieved via clustering the variables. To discover the clustering
structure of variables, it is intuitive that variables Xk and X` will be clustered in the same
group if |ρ1,k`| is large and separated otherwise (Wagaman and Levina, 2009). Specifically,
if there are some clustering structures among variables, then there exists a partition of
{1, . . . , p} upon potential permutations, denoted by {Bt}mt=1 for some 1 6 m 6 p, such
that mink,`∈Bt |ρ1,k`| > c1, and for any 1 6 t 6= t′ 6 m, maxk∈Bt,`∈Bt′ |ρ1,k`| < c2, where
c1, c2 > 0 are positive constants. The problem is then closely related to testing one-sample
hypotheses that for a given Λ ⊆ Ip = {(1, 1), . . . , (1, p), (2, 1), . . . , (2, p), . . . , (p, p)}, HΛ0 :
ρ1,k` = 0 for any (k, `) ∈ Λ versus HΛ1 : ρ1,k` 6= 0 for some (k, `) ∈ Λ, which is equivalent to
HΛ0 : σ1,k` = 0 for any (k, `) ∈ Λ versus HΛ1 : σ1,k` 6= 0 for some (k, `) ∈ Λ. (4.1)
Testing the hypothesis (4.1) facilitates recovering the dissimilarity patterns among variables;
that is, failing to reject HΛ0 indicates the segregation between Xk and X` whenever (k, `) ∈ Λ.
Motivated by the block-wise estimation method of Caragea and Smith (2007), we define Λ
in the following way. First, we place the covariance matrix Σ1 on a p× p grid indexed by Ip
and partition it with blocks of moderate size. Due to symmetry, we only focus on the upper
triangle part. Second, we construct blocks of size s0 × s0 along the diagonal and note that
the last block may be of a smaller size if s0 is not a divisor of p. Next, we create new blocks
of size s0 × s0 successively toward the top right corner. Similarly as before, blocks to the
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most right may be of smaller size. The grid, or equivalently, the index set Ip, is partitioned
into S = dp/s0e(dp/s0e+ 1)/2 sub-regions and we denote by Λ1, . . . ,ΛS the partition of the
upper triangle indices {(k, `) : 1 6 k < ` 6 p}.
On each of the sub-regions, we modify the proposed procedure for testing local hypotheses
HΛs0 : σ1,k` = 0 for any (k, `) ∈ Λs versus HΛs1 : σ1,k` 6= 0 for some (k, `) ∈ Λs, s = 1, . . . , S.
We then apply the Benjamini-Hochberg (BH) procedure to control the false discovery rate
(FDR) for simultaneously testing S hypotheses. For each s, failing to reject the null HΛs0
indicates a segregation between Xk and X` for (k, `) ∈ Λs and zero will be assigned as the
similarity between Xk and X`. We summarize this procedure as follows.
(I) Compute the sample covariance matrix Σ̂1 = (σˆ1,k`)16k,`6p and T̂ = (t˜k`)16k,`6p, where
t˜k` = n
1/2sˆ
−1/2
1,k` σˆ1,k` for sˆ1,k` defined in Section (2.2).
(II) Independent of Xn, simulate a sample of size B, where for each b = 1, . . . , B and
1 6 k 6 ` 6 p, compute t˜ †b,k` = (n−1sˆ1,k`)−1/2
∑n
i=1 gb,i{(Xik − X¯k)(Xi` − X¯`)− σˆ1,k`}, where
{gb,1, . . . , gb,n} is a sequence of i.i.d. standard normal random variables.
(III) Partition the p× p grid as discussed before by S blocks. For each block with entries
indexed by Λs ⊂ Ip, compute the approximated p-value as pˆs = 1 − F̂B
(
max(k,`)∈Λs t˜k`
)
,
where F̂B denotes the empirical (conditional) distribution function of max(k,`)∈Λs t˜k` given
Xn using the simulated samples {max(k,`)∈Λs t˜ †b,k`}Bb=1.
(IV) Estimate the q-values for {pˆs}Ss=1 using the BH procedure, denoted by {qˆs}. For a
prespecified cut-off pi, define the dissimilarity measure by
dk` = 1− t˜k`I(qˆs < pi)
max{max(k,`)∈Λs t˜k`, 1}
for any (k, `) ∈ Λs. (4.2)
Based on the measure in (4.2), we can apply clustering algorithms such as the hierarchical
clustering for clustering variables and obtain gene clustering. To specify the blocks, we
propose the following data-driven selection of s0. The S local hypotheses to be tested
simultaneously admit unknown complex dependencies so that the FDR, controlled by the
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BH procedure, satisfies the general upper bound FDR 6 (piS0 logS)/S where S0 denotes
the number of true null local hypotheses (Benjamini and Yekutieli, 2001). To control the
FDR at the nominal level pi, we need S > S0 logS which is automatically satisfied when
S = 1 or s0 is large. Therefore, we define a data-driven s0 by s0 = max{dlog pe,min(s :
Ŝ0(s) 6 S(s)[log{S(s)}]−1)}, where S(s) = dp/se(dp/se+ 1)/2 and Ŝ0 is an estimate for the
number of true null local hypotheses. In practice, we may also reorder the variables first using
methods such as the Isoband algorithm by Wagaman and Levina (2009). A demonstration of
the proposed clustering algorithm, as well as comparisons of dk` with traditional dissimilarity
measures based on the human asthma data, is displayed in the Supplementary Materials.
5. Application to analysis of human asthma data
5.1 Background
As a common chronic inflammatory disease of the airways, asthma is caused by a combination
of complex genetic and environmental interactions and affects more than 200 million people
worldwide as of 2013 as shown in 2013 World Health Organization Fact Sheet No. 307. The
mechanism and regulatory pathways remain unclear. We illustrate the proposed new proce-
dures using the human asthma data from the microarray experiment reported by Voraphani
et al. (2014), which was aimed to understand the regulatory pathway and mechanism for
high nitrative stress, a major characteristic of human severe asthma. Voraphani et al. (2014)
identified several novel pathways, including discovering that the Th1 cytokine, IFN-γ, along
or with Th2 regulations, are critical immune agents for the disease development by amplifying
epithelial NAD/NADPH thyroid oxidase expression and aiding the production of nitrite.
The original microarray gene expression data are available at the NCBI’s Gene Expression
Omnibus database with the Gene Expression Omnibus Series accession number GSE43696.
The data consist of n1 = 20 health samples and n2 = 88 patients suffering from moderate or
severe asthmatics. We focused on identifying disease-associated GO terms. After preliminary
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filtering steps using the approach in Gentleman et al. (2005) and removing genes without
appropriate annotations, there remained 24, 520 genes. We excluded GO terms with missing
information or less than 10 genes. There retained 3, 290 GO terms from the original dataset
whose sizes vary from 11 to 8, 070 genes. For g = 1, . . . , G with G = 3, 290, denote by µh,g
and µa,g the mean gene expression levels, and Σh,g and Σa,g the covariance matrices for the
gth GO term in the control and disease groups, respectively.
5.2 Differential expression analysis
A commonly used method in differential analysis is the mean-based test that selects interest-
ing GO terms by testing the null hypothesis that overall gene expressions within a GO term
are similar across populations (Chen and Qin, 2010; Chang et al., 2014; Wang et al., 2015).
Though the mean-based procedure has been successful in detecting differential expressed
genes based on the changes in the expression level, recent developments in genomic analysis
have revealed the importance to detect genes with changing relationships with other genes in
different biological states, and particularly GO terms that change the dependence structures
across populations (de la Fuente, 2010). The discovery of those GO terms with altered
dependence structures provides information on critical gene regulation pathways. Consider
all the GO terms, we applied the proposed method ΨB,α to test the global hypotheses
Hc0g : Σh,g = Σa,g versus H
c
1g : Σh,g 6= Σa,g. (5.1)
For a comparison, we also applied the LC and CLX tests.
Here, B = 5, 000 Monte Carlo replications were employed to compute the p-values for ΨB,α.
By controlling the FDR at 2.5% (Benjamini and Yekutieli, 2001), the proposed test ΨB,α
declared 969 GO terms significant while the LC and CLX tests declared 290 and 524 GO
terms significant, respectively. The proposed test ΨB,α has found more significant GO terms
and is less conservative than the others, which is also reflected by the histograms of p-values
for the three tests displayed in the Supplementary Material. Table 3 displays the top 15 most
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significant GO terms declared by ΨB,α and also highlights those GO terms that were not
detected by the LC and CLX tests. For example, GO:0005887 (integral to plasma membrane)
is functionally relevant to the dual oxidases (DUOX2)-thyroid peroxidase interaction and is
important to the mechanism of asthma development (Voraphani et al., 2014). It is worth
noticing that ΨB,α is able to discover this biologically important GO term that is missed by
the others. This further highlights the good performance of our proposed test.
[Table 3 about here.]
In addition, we compared the study on changing intergene relationships across biological
states with the traditional differential analysis based on mean expression levels. The proposed
test on intergene relationships discovered 268 significant GO terms that were missed by the
traditional differential analysis. This reflects the lately growing demands on analyzing gene
dependence structures. More details on this comparison are retained in the supplement.
5.3 Gene clustering study on GO terms of interest
Voraphani et al. (2014) revealed a novel pathway involving epithelial iNOS, dual oxidases,
TPO and the cytokine INF-γ to understand the mechanism of human asthma. Multiple
transcripts, together with their variants, are related, while their co-regulation mechanisms are
less clear. The proposed gene clustering algorithm provides a way to study gene interactions.
For illustration, we focus on the GO terms that were declared significant via testing (5.1)
and are related to IFN-γ or TPO, and apply our clustering procedure to the sample from
the health and disease groups separately to study how the gene clustering alters across two
populations. For IFN-γ, we consider the GO terms 0032689 (negative regulation of IFN-γ
production), 0060333 (IFN-γ-mediated signaling pathway) and 0071346 (cellular response
to IFN-γ). For TPO, the GO terms have been considered include 0004601 (peroxidase ac-
tivity), 0042446 (hormone biosynthetic process), 0035162 (embryonic hemopoiesis), 0006979
(response to oxidative stress), and 0009986 (cell surface). Their sizes vary from 17 to 439.
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[Figure 2 about here.]
We take B = 5, 000, α = 0.05 and use hierarchical clustering algorithm with average
linkage. The Ŝ0 is estimated using the censored Beta-Uniform mixture model by Markitsis
and Lai (2010) for selecting block size s0. Figures 2–3 display comparisons of gene clustering
between the health and disease groups (more comparisons are included in the Supplementary
Material). Each vertex in the figures represents a gene or its variant and is labelled by the
corresponding ID. Vertexes connected by edges in gray are clustered into one group, and
vertexes in red and yellow belong respectively to the maximum clique in the health and
disease groups. Vertexes in both colors belong to the maximum cliques for both groups.
From Figure 2 we see that for GO:0071346, regarding the cellular response to INF-γ, genes
tend to function more in clusters in the asthma group than those in the health group. Gene
TLR3 actively appears in the largest gene clusters for both the health and asthma groups,
while gene IL18 is isolated in the asthma group. Gene NOS2 is involved in asthma by
co-regulating with ARG2. These suggest that these four genes are important signatures for
understanding the effect of INF-γ on the asthma progression. Regarding the INF-γ-mediated
signaling pathway, Figure 2 also shows that compared to the health group, genes seem to
preferentially function separately in the asthma group. The original dominating gene clusters
are broken into small groups in the presence of the disease. The different configurations in
primary gene clusters between the health and asthma groups for GO:0060333 provide further
information on how INF-γ influences the iNOS pathway. For the critical enzyme TPO, Figure
3 shows that genes also tend to function in clusters in the disease group. In the presence of
asthma, the gene cluster HBB-HBA2.1-HBA2 is preserved and the gene IPCEF1 is isolated
from the original largest gene cluster for GO:0004601. It is interesting to notice that the
DUOX2 genes are isolated in the health group but do interact with many genes, particularly
with TPO, in the presence of asthma as documented in Voraphani et al. (2014). The identified
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DUOX2 gene cluster provides a candidate pathway to understand how TPO catalyzes the
iNOS-DUOX2-thyroid peroxidase pathway discovered by Voraphani et al. (2014). Last but
not least, it can be seen from Figure 3 that the overall co-regulation patterns remain similar
across populations, while those of TPO alters in the presence of asthma.
In summary, based on the proposed procedure, not only can we test the difference in gene
dependence, we can also discover the disparity in gene clustering, which reflects the difference
in gene clustering patterns between the health and disease groups.
[Figure 3 about here.]
6. Conclusion and discussion
In this paper, we proposed a computationally fast and effective procedure for testing the
equality of two large covariance matrices. The proposed procedure is powerful against sparse
alternatives corresponding to the situation where the two covariance matrices differ only in
a small fraction of entries. Compared to existing tests, the proposed procedure requires no
structural assumptions on the unknown covariance matrices and remains valid under mild
conditions. These appealing features grant the proposed test a vast applicability, particu-
larly for real problems arising in genomics. As an important application, we introduced a
gene clustering algorithm that enjoys the same nice feature of avoiding imposing structural
assumptions on the unknown covariance matrices.
Another interesting and related problem is testing the equality of two precision matrices,
which was recently studied by Xia et al. (2015). In the literature of graphical models, it is
common to impose the Gaussian assumption on data so that the conditional dependency
can be inferred based on the precision matrix. When the discrepancy between two precision
matrices is believed to be sparse, the data-dependent procedure considered in this paper
can be extended to comparing them by utilizing the similar L∞-type statistic discussed in
Xia et al. (2015). It is interesting to investigate whether our method can be applied to
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testing precision matrices in the presence of heavy-tailed data, which is often modeled by
the elliptical distribution family. We leave this to future work.
7. Supplementary Materials
Web Appendices, which include proofs of the main theorems and additional numerical results
referenced in Sections 2, 3 and 5 are available with this paper on the Biometrics website on
Wiley Online Library.
Acknowledgements
The authors thank the AE and two anonymous referees for constructive comments and
suggestions which have improved the presentation of the paper. Jinyuan Chang was sup-
ported in part by the Fundamental Research Funds for the Central Universities (Grant
No. JBK160159, JBK150501, JBK140507, JBK120509), NSFC (Grant No. 11501462), the
Center of Statistical Research at SWUFE and the Australian Research Council. Wen Zhou
was supported in part by NSF Grant IIS-1545994. Lan Wang was supported in part by NSF
Grant NSF DMS-1512267.
References
Anderson, T. W. (2003). An Introduction to Multivariate Statistical Analysis. 3rd edition.
New York: Wiley-Interscience.
Benjamini, Y. and Yekutieli, D. (2001). The control of the false discovery rate in multiple
testing under dependency. The Annals of Statistics 29, 1165–1188.
Cai, T. T., Liu, W., and Xia, Y. (2013). Two-sample covariance matrix testing and support
recovery in high-dimensional and sparse settings. Journal of the American Statistical
Association 108, 265–277.
Testing Large Covariance Matrices 19
Caragea, P. and Smith, R. (2007). Asymptotic properties of computationally efficient
alternative estimators for a class of multivariate normal models. Journal of Multivariate
Analysis 98, 1417–1440.
Chang, J., Zhou, W., and Zhou, W.-X. (2014). Simulation-based hypothesis testing of high
dimensional means under covariance heterogeneity. Available at arXiv:1406.1939.
Chen, S. X. and Qin, Y. (2010). A two-sample test for high-dimensional data with applica-
tions to gene-set testing. The Annals of Statistics 38, 808–835.
Chernozhukov, V., Chetverikov, D., and Kato, K. (2013). Gaussian approximations and
multiplier bootstrap for maxima of sums of high-dimensional random vectors. The Annals
of Statistics 41, 2786–2819.
de la Fuente, A. (2010). From differential expression to differential networking – identification
of dysfunctional regulatory networks in diseases. Trends in Genetics 26, 326–333.
D’haeseleer, P. (2005). How does gene expression clustering work? Nature Biotechnology 23,
1499–1501.
Gentleman, R., Irizarry, R. A., Carey, V. J., Dudoit, S., and Huber, W. (2005). Bioinformtics
and Computational Biology Solutions Using R and Bioconductor. New York: Springer-
Verlag.
Katsani, K. R., Irimia, M., Karapiperis, C., Scouras, Z. G., Blencowe, B. J., Promponas, V.
J., and Ouzounis, C. A. (2014). Functional genomics evidence unearths new moonlighting
roles of outer ring coat nucleoporins. Scientific Reports 4, 4655.
Li, J. and Chen, S. X. (2012). Two-sample tests for high-dimensional covariance matrices.
The Annals of Statistics 40, 908–940.
Liu, W., Lin, Z. Y. and Shao, Q.-M. (2008). The asymptotic distribution and Berry-Esseen
bound of a new test for independence in high dimension with an application to stochastic
optimization. The Annals of Applied Probability 18, 2337–2366.
20 Biometrics, September 2015
Markitsis, A. and Lai, Y. (2010). A censored beta mixture model for the estimation of the
proportion of non-differentially expressed genes. Bioinformatics 26, 640–646.
Schott, J. R. (2007). A test for the equality of covariance matrices when the dimension is large
relative to the sample size. Computational Statistics and Data Analysis 51, 6535–6542.
Sharan, R., Elkon, R., and Shamir, R. (2012). Cluster analysis and its applications to gene
expression data. Ernst Schering Research Foundation Workshop 38, 83–108.
Srivastava, M. S. and Yanagihara, H. (2010). Testing the equality of several covariance
matrices with fewer observations than the dimension. Journal of Multivariate Analysis
101, 1319–1329.
van der Vaart, A. W. and Wellner, J. A. (1996). Weak Convergence and Empirical Processes:
With Applications to Statistics. New York: Springer.
Voraphani, N., Gladwin, M. T., Contreras, A. U., Kaminski, N., Tedrow, J. R., Milosevic,
J., Bleecker, E. R., Meyers, D. A., Ray, A., Ray, P., Erzurum, S. C., Busse, W. W.,
Zhao, J., Trudeau, J. B., and Wenzel, S. E. (2014). An airway epithelial iNOS-DUOX2-
thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma.
Mucosal Immunology 7, 1175–1185.
Wolen, A. R. and Miles, M. F. (2012). Identifying gene networks underlying the neurobiology
of ethanol and alcoholism. Alcohol Research: Current Reviews 34, 306–317.
Wagaman, A. S. and Levina, E. (2009). Discovering sparse covariance structures with the
Isomap. Journal of Computational and Graphical Statistics 18, 551–572.
Wang, L., Peng, B., and Li., R. (2015). A high-dimensional nonparametric multivariate test
for mean vector. Journal of the American Statistical Association 110, 1658–1669.
Xia, Y., Cai, T., and Cai, T. T. (2015). Testing differential networks with applications to
the detection of gene-gene interactions. Biometrika 94, 247–266.
Yi, G., Sze, S.-H., and Thon, M. (2007). Identifying clusters of functionally related genes in
Testing Large Covariance Matrices 21
genomes. Bioinformatics 23, 1053–1060.
Received September 2015.
22 Biometrics, September 2015
l
l
l
l
0.0
0.2
0.4
0.6
0.8
1.
0
D1
l
l l l
80 280 500 1000
l
l
l
l
0.0
0.2
0.4
0.6
0.8
1.
0
D2
l
l
l
l
80 280 500 1000
l
l l
l
0.0
0.2
0.4
0.6
0.8
1.
0
D3
l
l l
l
80 280 500 1000
(a) Covariance structure M1
l
l
l
l
0.0
0.2
0.4
0.6
0.8
1.
0
D1
l
l
l l
80 280 500 1000
l
l
l
l
0.0
0.2
0.4
0.6
0.8
1.
0
D2
l
l
l
l
80 280 500 1000
l
l
l l
0.0
0.2
0.4
0.6
0.8
1.
0
D3
l
l
l
l
80 280 500 1000
(b) Covariance structure M2
l
l
l
l
0.0
0.2
0.4
0.6
0.8
1.
0
D1
l
l l l
80 280 500 1000
l
l
l
l
0.0
0.2
0.4
0.6
0.8
1.
0
D2
l
l
l
l
80 280 500 1000
l l l
l
0.0
0.2
0.4
0.6
0.8
1.
0
D3
l
l
l
l
80 280 500 1000
(c) Covariance structure M3
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(d) Covariance structure M4
Figure 1: Comparison of empirical powers for data generated by data models D1–D3 with
different covariance structures. In each panel, horizontal and vertical axes depict dimension p
and empirical powers, respectively; and unbroken lines and dashed lines represent the results
for (n1, n2) = (45, 45) and (60, 80), respectively. The different symbols on the lines represent
different tests experimented in the study, where ◦, @, and + indicate the proposed test,
tests by Li and Chen (2012) and Cai et al. (2013), respectively. Results are based on 1000
replications with α = 0.05.
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(a) GO:0071346, cellular response to INF-γ
(b) GO:0060333, INF-γ-mediated signaling pathway
Figure 2: Comparison of clustering structures of GO:0071346, cellular response to INF-
γ and GO:0060333, INF-γ-mediated signaling pathway, between health and disease groups
using the proposed gene clustering procedure. This figure appears in color in the electronic
version of this article.
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(a) GO:0004601, peroxidase activity
(b) GO:0035162, embryonic hemopoiesis
Figure 3: Comparison of clustering structures of GO:0004601, peroxidase activity and
GO:0035162, embryonic hemopoiesis, between health and disease groups using the proposed
gene clustering procedure. This figure appears in color in the electronic version of this article.
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0.039
0.038
0.036
0.040
0.038
0.043
0.043
0.053
0.018
0.023
0.024
0.025
L
C
0.066
0.063
0.074
0.040
0.086
0.053
0.072
0.068
0.337
0.335
0.343
0.342
S
c
0.108
0.104
0.134
0.098
0.651
0.674
0.644
0.662
1.000
1.000
1.000
1.000
C
L
X
0.034
0.032
0.029
0.031
0.028
0.035
0.035
0.025
0.006
0.011
0.006
0.005
C
ovarian
ce
stru
ctu
re
M
4
w
ith
(n
1 ,n
2 )
=
(45,45)
Ψ
B
,α
0.054
0.056
0.056
0.078
0.052
0.079
0.086
0.086
0.021
0.031
0.031
0.027
L
C
0.063
0.068
0.055
0.060
0.064
0.070
0.070
0.053
0.323
0.311
0.343
0.318
S
c
0.117
0.107
0.098
0.120
0.595
0.606
0.632
0.621
1.000
1.000
1.000
1.000
C
L
X
0.049
0.049
0.043
0.037
0.045
0.066
0.040
0.076
0.009
0.011
0.004
0.004
C
ovarian
ce
stru
ctu
re
M
4
w
ith
(n
1 ,n
2 )
=
(60,80)
Ψ
B
,α
0.044
0.050
0.036
0.042
0.047
0.042
0.047
0.055
0.029
0.013
0.022
0.024
L
C
0.053
0.058
0.054
0.055
0.104
0.049
0.070
0.051
0.340
0.334
0.335
0.341
S
c
0.110
0.100
0.117
0.111
0.618
0.650
0.641
0.682
1.000
1.000
1.000
1.000
C
L
X
0.038
0.036
0.036
0.032
0.036
0.037
0.039
0.025
0.016
0.004
0.006
0.004
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Table 3: Top 15 most significant GO terms detected by ΨB,α with FDR controlled at 2.5%,
[ and † refer to the GO terms not being declared significant by the CLX test and the LC
test, respectively.
GO ID GO term name
GO:0006886 intracellular protein transport †
GO:0008565 protein transporter activity †
GO:0030117 membrane coat †
GO:0005515 protein binding[,†
GO:0016032 viral reproduction[,†
GO:0005829 cytosol†
GO:0000278 mitotic cell cycle†
GO:0006334 nucleosome assembly†
GO:0034080 CenH3-containing nucleosome assembly at centromere
GO:0006974 response to DNA damage stimulus†
GO:0016874 ligase activity†
GO:0032007 negative regulation of TOR signaling cascade†
GO:0005887 integral to plasma membrane[,†
GO:0006997 nucleus organization†
GO:0030154 cell differentiation†
